{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:34:46Z","timestamp":1773160486624,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fujian Provincial Natural Science Foundation of China","award":["2021J01783"],"award-info":[{"award-number":["2021J01783"]}]},{"name":"2023 Fujian provincial key clinical specialty construction project","award":["[2023]1163"],"award-info":[{"award-number":["[2023]1163"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-025-11115-8","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T08:38:28Z","timestamp":1738312708000},"page":"5907-5923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Discovery of natural products as influenza neuraminidase inhibitors: in silico screening, in vitro validation, and molecular dynamic simulation studies"],"prefix":"10.1007","volume":"29","author":[{"given":"Binglin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maobai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"11115_CR1","unstructured":"Influenza (Seasonal). Word Health Organization (WHO) Report. 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)?gad_source=1&gclid=Cj0KCQiA--6BhCBARIsADYqyL_rPaUiEXiG3RyDJNV0YVoz2c6o10QuFfUjQn8SJ8p4lPVlbSiVe_waAr2qEALw_wcB"},{"issue":"10127","key":"11115_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S et al (2018) Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391(10127):1285\u20131300","journal-title":"Lancet"},{"key":"11115_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-11155-1","volume-title":"Influenza pathogenesis and control-volume I","author":"RW Compans","year":"2014","unstructured":"Compans RW, Oldstone MB (2014) Influenza pathogenesis and control-volume I. Springer, Berlin"},{"issue":"3","key":"11115_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003550","volume":"18","author":"KE Lafond","year":"2021","unstructured":"Lafond KE, Porter RM, Whaley MJ, Suizan Z, Ran Z, Aleem MA et al (2021) Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: a systematic review and meta-analysis. PLoS Med 18(3):e1003550","journal-title":"PLoS Med"},{"issue":"3","key":"11115_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrmicro3200","volume":"12","author":"V Dartois","year":"2014","unstructured":"Dartois V (2014) The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol 12(3):159\u2013167","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"11115_CR6","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1038\/ncomms4630","volume":"5","author":"R Huether","year":"2014","unstructured":"Huether R, Dong L, Chen X, Wu G, Parker M, Wei L et al (2014) The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun 5(1):3630","journal-title":"Nat Commun"},{"issue":"31","key":"11115_CR7","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1016\/j.vaccine.2010.05.031","volume":"28","author":"MP Girard","year":"2010","unstructured":"Girard MP, Tam JS, Assossou OM, Kieny MP (2010) The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 28(31):4895\u20134902","journal-title":"Vaccine"},{"issue":"7","key":"11115_CR8","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/ijms18071541","volume":"18","author":"L Byrd-Leotis","year":"2017","unstructured":"Byrd-Leotis L, Cummings RD, Steinhauer DA (2017) The interplay between the host receptor and influenza virus hemagglutinin and neuraminidase. Int J Mol Sci 18(7):1541","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11115_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","volume":"19","author":"C-J Wei","year":"2020","unstructured":"Wei C-J, Crank MC, Shiver J, Graham BS, Mascola JR, Nabel GJ (2020) Next-generation influenza vaccines: opportunities and challenges. Nat Rev Drug Discov 19(4):239\u2013252","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"11115_CR10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","volume":"39","author":"T Lampejo","year":"2020","unstructured":"Lampejo T (2020) Influenza and antiviral resistance: an overview. Eur J Clin Microbiol Infect Dis 39(7):1201\u20131208","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"11115_CR11","doi-asserted-by":"crossref","unstructured":"Tripp RA, Bakre A, Stambas J (2019) Understanding the limitations of current Influenza vaccine strategies and future development of more efficacious preventative and therapeutic interventions. Frontiers Media SA, p 2804","DOI":"10.3389\/fimmu.2019.02804"},{"issue":"10","key":"11115_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC et al (2018) Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 379(10):913\u2013923","journal-title":"N Engl J Med"},{"issue":"9979","key":"11115_CR13","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","volume":"385","author":"J Dobson","year":"2015","unstructured":"Dobson J, Whitley RJ, Pocock S, Monto AS (2015) Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 385(9979):1729\u20131737","journal-title":"Lancet"},{"issue":"1","key":"11115_CR14","first-page":"49","volume":"168","author":"G Stiver","year":"2003","unstructured":"Stiver G (2003) The treatment of influenza with antiviral drugs. CMAJ 168(1):49\u201357","journal-title":"CMAJ"},{"key":"11115_CR15","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","volume":"26","author":"NM Bouvier","year":"2008","unstructured":"Bouvier NM, Palese P (2008) The biology of influenza viruses. Vaccine 26:D49\u2013D53","journal-title":"Vaccine"},{"issue":"4","key":"11115_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.7150\/thno.17071","volume":"7","author":"X Wu","year":"2017","unstructured":"Wu X, Wu X, Sun Q, Zhang C, Yang S, Li L et al (2017) Progress of small molecular inhibitors in the development of anti-influenza virus agents. Theranostics 7(4):826","journal-title":"Theranostics"},{"issue":"1","key":"11115_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/C1NP00053E","volume":"29","author":"U Grienke","year":"2012","unstructured":"Grienke U, Schmidtke M, von Grafenstein S, Kirchmair J, Liedl KR, Rollinger JM (2012) Influenza neuraminidase: a druggable target for natural products. Nat Prod Rep 29(1):11\u201336","journal-title":"Nat Prod Rep"},{"issue":"11","key":"11115_CR18","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/molecules21111513","volume":"21","author":"P Laborda","year":"2016","unstructured":"Laborda P, Wang S-Y, Voglmeir J (2016) Influenza neuraminidase inhibitors: synthetic approaches, derivatives and biological activity. Molecules 21(11):1513","journal-title":"Molecules"},{"issue":"11","key":"11115_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224683","volume":"14","author":"M Mawatari","year":"2019","unstructured":"Mawatari M, Saito R, Hibino A, Kondo H, Yagami R, Odagiri T et al (2019) Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza. PLoS ONE 14(11):e0224683","journal-title":"PLoS ONE"},{"key":"11115_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11908-012-0236-x","volume":"14","author":"S Shankaran","year":"2012","unstructured":"Shankaran S, Bearman GM (2012) Influenza virus resistance to neuraminidase inhibitors: implications for treatment. Curr Infect Dis Rep 14:155\u2013160","journal-title":"Curr Infect Dis Rep"},{"key":"11115_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-11-134","volume":"11","author":"K Thorlund","year":"2011","unstructured":"Thorlund K, Awad T, Boivin G, Thabane L (2011) Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis 11:1\u201313","journal-title":"BMC Infect Dis"},{"issue":"4","key":"11115_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/ph14040371","volume":"14","author":"J Ye","year":"2021","unstructured":"Ye J, Lin L, Xu J, Chan PK, Yang X, Ma C (2021) Design, synthesis, biological evaluation and in silico studies of Pyrazole-based NH2-acyl oseltamivir analogues as potent neuraminidase inhibitors. Pharmaceuticals 14(4):371","journal-title":"Pharmaceuticals"},{"issue":"2","key":"11115_CR23","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/02648725.2023.2191081","volume":"40","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty S, Chauhan A (2024) Fighting the flu: a brief review on anti-influenza agents. Biotechnol Genet Eng Rev 40(2):858\u2013909","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"2","key":"11115_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/17460441.2019.1560261","volume":"14","author":"W-J Shin","year":"2019","unstructured":"Shin W-J, Seong BL (2019) Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains. Expert Opin Drug Discov 14(2):153\u2013168","journal-title":"Expert Opin Drug Discov"},{"issue":"12","key":"11115_CR25","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1039\/c0np00005a","volume":"27","author":"H Ge","year":"2010","unstructured":"Ge H, Wang Y-F, Xu J, Gu Q, Liu H-B, Xiao P-G et al (2010) Anti-influenza agents from traditional Chinese medicine. Nat Prod Rep 27(12):1758\u20131780","journal-title":"Nat Prod Rep"},{"issue":"6","key":"11115_CR26","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/med.21707","volume":"40","author":"ZJ Zhang","year":"2020","unstructured":"Zhang ZJ, Morris-Natschke SL, Cheng YY, Lee KH, Li RT (2020) Development of anti-influenza agents from natural products. Med Res Rev 40(6):2290\u20132338","journal-title":"Med Res Rev"},{"key":"11115_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113523","volume":"153","author":"M Yang","year":"2022","unstructured":"Yang M, Wang Y, Yue Y, Liang L, Peng M, Zhao M et al (2022) Traditional Chinese medicines as effective agents against influenza virus-induced pneumonia. Biomed Pharmacother 153:113523","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"11115_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.sjbs.2014.09.009","volume":"22","author":"KM John","year":"2015","unstructured":"John KM, Enkhtaivan G, Ayyanar M, Jin K, Yeon JB, Kim DH (2015) Screening of ethnic medicinal plants of South India against influenza (H1N1) and their antioxidant activity. Saudi J Biol Sci 22(2):191\u2013197","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"11115_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5024","volume":"35","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Zhang X, Cao Y, Huang L (2021) The exploration of neuraminidase inhibitory activity on Fallopia denticulata, an ethnic herb in China. Biomed Chromatogr 35(4):e5024","journal-title":"Biomed Chromatogr"},{"key":"11115_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.575803","volume":"11","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Li NX, Duan N, Liu B, Zhu H, Zhang C et al (2020) Traditional Chinese medicine in treating influenza: from basic science to clinical applications. Front Pharmacol 11:575803","journal-title":"Front Pharmacol"},{"issue":"24","key":"11115_CR31","doi-asserted-by":"publisher","first-page":"13371","DOI":"10.1128\/JVI.01426-12","volume":"86","author":"X Zhu","year":"2012","unstructured":"Zhu X, McBride R, Nycholat CM, Yu W, Paulson JC, Wilson IA (2012) Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. J Virol 86(24):13371\u201313383","journal-title":"J Virol"},{"key":"11115_CR32","doi-asserted-by":"publisher","first-page":"111635","DOI":"10.1016\/j.ejmech.2019.111635","volume":"182","author":"J Ye","year":"2019","unstructured":"Ye J, Yang X, Xu M, Chan PK, Ma C (2019) Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: design, synthesis, biological evaluation, ADME prediction and molecular docking studies. Eur J Med Chem 182:111635","journal-title":"Eur J Med Chem"},{"issue":"9","key":"11115_CR33","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072","journal-title":"J Med Chem"},{"issue":"3","key":"11115_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/prot.340140302","volume":"14","author":"JN Varghese","year":"1992","unstructured":"Varghese JN, McKimm-Breschkin JL, Caldwell JB, Kortt AA, Colman PM (1992) The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins Struct Funct Bioinform 14(3):327\u2013332","journal-title":"Proteins Struct Funct Bioinform"},{"key":"11115_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejmech.2019.05.076","volume":"178","author":"R Jia","year":"2019","unstructured":"Jia R, Zhang J, Ai W, Ding X, Desta S, Sun L et al (2019) Design, synthesis and biological evaluation of \u201cMulti-Site\u201d-binding influenza virus neuraminidase inhibitors. Eur J Med Chem 178:64\u201380","journal-title":"Eur J Med Chem"},{"issue":"1","key":"11115_CR36","doi-asserted-by":"publisher","first-page":"17796","DOI":"10.1038\/s41598-022-22668-1","volume":"12","author":"AR Issahaku","year":"2022","unstructured":"Issahaku AR, Mukelabai N, Agoni C, Rudrapal M, Aldosari SM, Almalki SG et al (2022) Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy. Sci Rep 12(1):17796","journal-title":"Sci Rep"},{"issue":"1","key":"11115_CR37","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1038\/s41598-023-35161-0","volume":"13","author":"M Rudrapal","year":"2023","unstructured":"Rudrapal M, Eltayeb WA, Rakshit G, El-Arabey AA, Khan J, Aldosari SM et al (2023) Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies. Sci Rep 13(1):8656","journal-title":"Sci Rep"},{"issue":"24","key":"11115_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202300277","volume":"8","author":"AR Issahaku","year":"2023","unstructured":"Issahaku AR, Salifu EY, Agoni C, Alahmdi MI, Abo-Dya NE, Soliman ME et al (2023) Discovery of potential KRAS-SOS1 inhibitors from South African natural compounds: an in silico approach. ChemistrySelect 8(24):e202300277","journal-title":"ChemistrySelect"},{"issue":"5","key":"11115_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202103908","volume":"7","author":"JA Ezugwu","year":"2022","unstructured":"Ezugwu JA, Okoro UC, Ezeokonkwo MA, Hariprasad KS, Rudrapal M, Ugwu DI et al (2022) Design, synthesis, molecular docking, molecular dynamics and in vivo antimalarial activity of new dipeptide-sulfonamides. ChemistrySelect 7(5):e202103908","journal-title":"ChemistrySelect"},{"key":"11115_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.130862","volume":"1243","author":"IM Othman","year":"2021","unstructured":"Othman IM, Mahross MH, Gad-Elkareem MA, Rudrapal M, Gogoi N, Chetia D et al (2021) Toward a treatment of antibacterial and antifungal infections: design, synthesis and in vitro activity of novel arylhydrazothiazolylsulfonamides analogues and their insight of DFT, docking and molecular dynamic simulations. J Mol Struct 1243:130862","journal-title":"J Mol Struct"},{"key":"11115_CR41","doi-asserted-by":"publisher","first-page":"1185236","DOI":"10.3389\/fnut.2023.1185236","volume":"10","author":"R Baru Venkata","year":"2023","unstructured":"Baru Venkata R, Prasanth DSNBK, Pasala PK, Panda SP, Tatipamula VB, Mulukuri S et al (2023) Utilizing Andrographis paniculata leaves and roots by effective usage of the bioactive andrographolide and its nanodelivery: Investigation of antikindling and antioxidant activities through in silico and in vivo studies. Front Nutr 10:1185236","journal-title":"Front Nutr"},{"issue":"2","key":"11115_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260180","volume":"17","author":"L Qin","year":"2022","unstructured":"Qin L, Kuai J, Yang F, Yang L, Sun P, Zhang L et al (2022) Selected by bioinformatics and molecular docking analysis, Dhea and 2\u201314, 15-Eg are effective against cholangiocarcinoma. PLoS ONE 17(2):e0260180","journal-title":"PLoS ONE"},{"key":"11115_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-020-0408-x","volume":"12","author":"N Schaduangrat","year":"2020","unstructured":"Schaduangrat N, Lampa S, Simeon S, Gleeson MP, Spjuth O, Nantasenamat C (2020) Towards reproducible computational drug discovery. J Cheminformatics 12:1\u201330","journal-title":"J Cheminformatics"},{"issue":"23","key":"11115_CR44","doi-asserted-by":"publisher","first-page":"14525","DOI":"10.1039\/D2CP00464J","volume":"24","author":"S Maier","year":"2022","unstructured":"Maier S, Thapa B, Erickson J, Raghavachari K (2022) Comparative assessment of QM-based and MM-based models for prediction of protein\u2013ligand binding affinity trends. Phys Chem Chem Phys 24(23):14525\u201314537","journal-title":"Phys Chem Chem Phys"},{"issue":"1","key":"11115_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103374","volume":"28","author":"RK Kar","year":"2023","unstructured":"Kar RK (2023) Benefits of hybrid QM\/MM over traditional classical mechanics in pharmaceutical systems. Drug Discov Today 28(1):103374","journal-title":"Drug Discov Today"},{"issue":"3","key":"11115_CR46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1529\/biophysj.106.092528","volume":"92","author":"O Aruksakunwong","year":"2007","unstructured":"Aruksakunwong O, Malaisree M, Decha P, Sompornpisut P, Parasuk V, Pianwanit S et al (2007) On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9. Biophys J 92(3):798\u2013807","journal-title":"Biophys J"},{"key":"11115_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106983","volume":"143","author":"J Ye","year":"2024","unstructured":"Ye J, Kan CH, Zheng Y, Tsang TF, Chu AJ, Chan KH et al (2024) Sulfonamidyl derivatives of sigmacidin: protein\u2013protein interaction inhibitors targeting bacterial RNA polymerase and sigma factor interaction exhibiting antimicrobial activity against antibiotic-resistant bacteria. Bioorg Chem 143:106983","journal-title":"Bioorg Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11115-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:02:22Z","timestamp":1764784942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11115-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11115"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11115-8","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}